Soros continues raising Teva holding

Indicators point to strong investor confidence in Israel

Soros Fund Management bought 5.7 million Teva shares in the fourth quarter of 2013.

The family office of George Soros, Soros Fund Management LLC, continues to purchase shares in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), the fund's quarterly report to the US Securities and Exchange Commission (SEC) reveals.

Sphera: Teva lacks growth engines

Copaxone provided 63% of Teva's operating profit

Goldman Sachs: Copaxone saved Teva in 2013

Teva seen as Valeant target

Teva can't fall much further

During the fourth quarter of 2013, Soros bought a further 5.7 million Teva shares, raising his holding in the Israeli pharmaceuticals company to some $373 million. Teva is the $9.8 billion fund's largest holding.

In the third quarter of 2013, Soros bought 3.6 million Teva shares for some $136 million.

Published by Globes [online], Israel business news - www.globes-online.com - on February 16, 2014